Press release
Idiopathic Pulmonary Fibrosis Market Size Worth USD 6.16 billion by 2030 at a CAGR of 7.0%
The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
What are the factors driving the Idiopathic Pulmonary Fibrosis Market?
Increase in incidences of cancer worldwide, favorable reimbursement policies provided by manufacturers & insurance providers, and rise in cigarette smoking drive the growth of the global idiopathic pulmonary fibrosis market. However, the unavailability of the proper treatment options restrains the market growth. On the other hand, rise in number of pipeline drugs and untapped potential in developing countries present new opportunities in the coming years.
Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/4407
Top Idiopathic Pulmonary Fibrosis Companies
• AstraZeneca PLC
• Bristol-Myers Squibb Company
• Boehringer Ingelheim
• GNI Group Ltd
• F. Hoffmann-La Roche Ltd. (Genentech, Inc.,)
• Shiongi co Ltd
• Mission Therapeutics
• Biogen, Inc.
• Galapagos NV
• FibroGen, Inc.
Idiopathic Pulmonary Fibrosis Market segmentation can be done based on several factors, including:
Based on drug type, the pirfenidone segment accounted for the highest share in 2020, holding around three-fourths of the global idiopathic pulmonary fibrosis market, and is expected to continue its leadership status during the forecast period. Moreover, this segment is projected to manifest the highest CAGR of 7.2% from 2021 to 2030. This is due to rise in adoption of pirfenidone drugs such as Esbriet and Pirespa across the world. The research also analyzes the nintedanib segment.
Based on distribution channel, the retail pharmacies segment accounted for the highest share in 2020, contributing to nearly half of the global idiopathic pulmonary fibrosis market, and is estimated to continue its lead position during the forecast period. This is attributed to rapid increase in rate of idiopathic pulmonary fibrosis among the geriatric population, technological advancements, and lifestyle changes worldwide. However, the online providers segment is expected to portray the largest CAGR of 8.5% from 2021 to 2030. This is due to offers and discounts offered by providers and the availability of different types of drugs under a single platform.
Based on region, North America contributed to the highest market share in 2020, holding more than two-fifths of the global idiopathic pulmonary fibrosis market, and is projected to continue its lead in terms of revenue by 2030. This is attributed to high expenditure on R&D activities, presence of major players & their product availability, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to manifest the fastest CAGR of 8.9% during the forecast period, owing to improvement in R&D facilities and rapidly developing economic conditions.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/4407
Our Market Research Solution Provides You Answer to Below Mentioned Question:
• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?
By Region Outlook
• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Idiopathic Pulmonary Fibrosis Market Size Worth USD 6.16 billion by 2030 at a CAGR of 7.0% here
News-ID: 4011677 • Views: …
More Releases from Allied Market Research (AMR)
Melamine Market Exclusive Report on the Latest Revenue and Future Scope
According to a new report published by Allied Market Research, titled "Melamine Market by Type (Melamine Foam and Melamine Resin) and Application (Laminates, Thermoset Plastics, Wood Adhesives, Surface Coatings, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030," the global melamine market was valued at $1.7 billion in 2020 and is projected to reach $2.5 billion by 2030, registering a CAGR of 4.3% from 2021 to 2030.
Download Sample Pages of…
Optical Ceramics Market Exclusive Report with Detailed Study Analysis
According to Allied Market Research, the global optical ceramics market was valued at $189.3 million in 2020 and is projected to reach $603.4 million by 2030, registering a robust CAGR of 12.4% from 2021 to 2030. The market report provides an in-depth analysis of operating business segments, product portfolios, overall business performance, and key strategic developments shaping the competitive landscape. Leading companies, including Celanese Corporation, are extensively profiled, highlighting their…
Denim Fabric Market Know the Scope and Trends
The global denim fabric market is witnessing steady growth, driven by the wide availability of denim at affordable prices and evolving socio-economic trends such as changing fashion preferences and rising urbanization. In 2020, the Asia-Pacific (APAC) region dominated the market, accounting for nearly four-fifths of the total revenue.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A14268
According to a report published by Allied Market Research, the global denim fabric market was valued…
Aminoethylethanolamine Market Report on the Untapped Growth Opportunities in the …
According to a new report published by Allied Market Research, titled, "Aminoethylethanolamine Market by Grade and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030, "The global aminoethylethanolamine market was valued at $222.5 million in 2020, and is projected to reach $357.5 million by 2030, growing at a CAGR of 4.9% from 2021 to 2030.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A13786
Aminoethylethanolamine is a high purity organic base chemical compound that is…
More Releases for Idiopathic
Idiopathic Pulmonary Fibrosis Market Size & Share Analysis
The new report published by The Business Research Company, titled Idiopathic Pulmonary Fibrosis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the idiopathic pulmonary fibrosis market size has grown strongly in recent years. It will grow from $3.89…
Charting New Frontiers: Idiopathic Gastroparesis Drugs Market Dynamics
The Idiopathic Gastroparesis Drugs Market 𝐑𝐞𝐩𝐨𝐫𝐭 dissects the complex fragments of the Market in an easy-to-read manner. This report covers drivers, restraints, challenges, and threats in the Idiopathic Gastroparesis Drugs Market to understand the overall scope of the Market in a detailed yet concise manner.
Additionally, the Market report covers the top-winning strategies implemented by major industry players and technological advancements that steer the growth of the Market.
𝐂𝐥𝐚𝐢𝐦 𝐲𝐨𝐮𝐫 𝐂𝐨𝐩𝐲…
Chronic Idiopathic Myelofibrosis Market 2022 | Detailed Report
The Chronic Idiopathic Myelofibrosis report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry.
The Chronic Idiopathic Myelofibrosis report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,…
Idiopathic Membranous Nephropathy Treatment Market to Witness Significant Growth …
Idiopathic membranous nephropathy a glomerular disease usually of abrupt onset and associated with the nephrotic syndrome. Membranous nephropathy occurs when the small blood vessels in the kidney (glomeruli), which filter wastes from the blood, become damaged and thickened. As a result, proteins leak from the damaged blood vessels into the urine (proteinuria).
R&D in idiopathic membranous nephropathy is expected to aid in growth of the idiopathic membranous nephropathy treatment market. In…
Global Idiopathic Scoliosis Treatment Market Size by Type (Infantile Idiopathic, …
Global Idiopathic Scoliosis Treatment Market Research report provides vital information related to the overall market and forecast from 2019 to 2026. This report includes the in-depth analysis of market size, share, growth, trends and regional demand and top layers the Idiopathic Scoliosis Treatment Market. The major players dominating the market are focused upon throughout the by analyzing their revenue, their business summary, product segmentation along with the latest developments.
Get Sample…
Chronic Idiopathic Constipation Market Research Report 2024
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipation…
